Protekt Therapeutics
Alzheimer’s disease drug | Protekt Therapeutics | Israel.
Launch date
Ness Ziona Center District (HQ)
Date | Investors | Amount | Round |
---|---|---|---|
$4.1m | Early VC | ||
Total Funding | $4.1m |
Related Content
Recent News about Protekt Therapeutics
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.